Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Am J Perinatol ; 36(10): 1060-1065, 2019 08.
Artículo en Inglés | MEDLINE | ID: mdl-30500959

RESUMEN

OBJECTIVE: Transcription of human endogenous retrovirus (HERV) elements is usually suppressed by epigenetic factors such as DNA methylation and heterochromatin silencing by histone modifications. There is an association between maternal smoking during pregnancy and DNA methylation levels in placental tissue and in DNA from cord blood. STUDY DESIGN: We assessed the transcriptional activity of HERV-H, HERV-K, and HERV-W in umbilical cord blood from 47 term babies unexposed to tobacco smoke in utero and 23 term babies exposed to tobacco smoke in utero. RESULTS: In our population, the HERV-H, HERV-K, and HERV-W families were always transcriptionally active, and the levels of all HERVs (H, K, W) were significantly higher in unexposed than smoke-exposed babies. CONCLUSION: This study provides preliminary information about the transcriptional activity of HERV-H, HERV-K, and HERV-W families in human umbilical cord blood.


Asunto(s)
Fumar Cigarrillos , Retrovirus Endógenos/genética , Sangre Fetal/metabolismo , Exposición Materna/efectos adversos , Transcripción Genética/efectos de los fármacos , Metilación de ADN , Retrovirus Endógenos/metabolismo , Femenino , Expresión Génica , Humanos , Recién Nacido , Embarazo
2.
J Clin Invest ; 109(1): 111-9, 2002 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-11781356

RESUMEN

Modified LDL is a major cause of injury to the endothelium in diabetes. In the present study, we analyzed the effects on endothelial cells of LDL recovered from type 2 diabetic patients (dm-LDL) or from nondiabetic subjects (n-LDL). Treatment of human umbilical vein endothelial cells with dm-LDL, but not n-LDL, led to the accumulation of cells in G1. To dissect the molecular mechanisms of this effect, we analyzed the expression and function of the cyclin-dependent kinase inhibitor p21(waf), a cell cycle regulator known to be a target of the signal transducers and activators of transcription (STATs). dm-LDL led to transient STAT5 phosphorylation and the formation of a STAT5-containing complex and activated p21(waf) expression at the transcriptional level. Expression of the dominant-negative form of STAT5B, but not of STAT5A, significantly decreased both p21(waf) expression and the fraction of cells in G1. Finally, immunofluorescence analysis demonstrated that activated STAT5 is expressed in newly formed intraplaque vessels and in endothelial cells lining the luminal side of the plaque. Similarly, p21(waf) immunoreactivity was found in the neointimal vasculature. Our results suggest a role of STAT5B as a regulator of gene expression in diabetes-associated vascular disease.


Asunto(s)
Quinasas CDC2-CDC28 , Ciclo Celular/efectos de los fármacos , Ciclinas/metabolismo , Proteínas de Unión al ADN/metabolismo , Diabetes Mellitus Tipo 2/sangre , Lipoproteínas LDL/sangre , Lipoproteínas LDL/farmacología , Proteínas de la Leche , Transactivadores/metabolismo , Anciano , Arteriosclerosis/sangre , Arteriosclerosis/etiología , Arteriosclerosis/patología , Estudios de Casos y Controles , Ciclo Celular/fisiología , Células Cultivadas , Quinasa 2 Dependiente de la Ciclina , Inhibidor p21 de las Quinasas Dependientes de la Ciclina , Quinasas Ciclina-Dependientes/metabolismo , Ciclinas/genética , Proteínas de Unión al ADN/genética , Angiopatías Diabéticas/sangre , Angiopatías Diabéticas/etiología , Angiopatías Diabéticas/patología , Endotelio Vascular/efectos de los fármacos , Endotelio Vascular/patología , Femenino , Fase G1/efectos de los fármacos , Fase G1/fisiología , Regulación de la Expresión Génica/efectos de los fármacos , Humanos , Lipoproteínas LDL/aislamiento & purificación , Masculino , Persona de Mediana Edad , Proteínas Serina-Treonina Quinasas/metabolismo , Especies Reactivas de Oxígeno/metabolismo , Factor de Transcripción STAT5 , Transactivadores/genética , Proteínas Supresoras de Tumor
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA